InsidersTradesSigma
Browse the detailed record of transactions filed by CHAUSSY STEVE, Chief Financial Officer. Director active across 1 companies, notably BioSig Technologies, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €6k. The latest transaction was filed on 21 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Steve Chaussey serves as Chief Financial Officer at BioSig Technologies, Inc. He manages the financial operations and strategy of the company, which specializes in medical technologies. Steve Chaussey plays a crucial role in financial planning and performance analysis.